Skip to main content
Top
Published in: BMC Cancer 1/2012

Open Access 01-12-2012 | Case report

A rare case of primary clear cell sarcoma of the pubic bone resembling small round cell tumor: an unusual morphological variant

Authors: Shoko Nakayama, Taiji Yokote, Kazuki Iwaki, Toshikazu Akioka, Takuji Miyoshi, Yuji Hirata, Ayami Takayama, Uta Nishiwaki, Yuki Masuda, Motomu Tsuji, Toshiaki Hanafusa

Published in: BMC Cancer | Issue 1/2012

Login to get access

Abstract

Background

Clear cell sarcoma (CCS) and malignant melanoma share overlapping immunohistochemistry with regard to the melanocytic markers HMB45, S100, and Melan-A. However, the translocation t(12; 22)(q13; q12) is specific to CCS. Therefore, although these neoplasms are closely related, they are now considered to be distinct entities. However, the translocation is apparently detectable only in 50%–70% of CCS cases. Therefore, the absence of a detectable EWS/AFT1 rearrangement may occasionally lead to erroneous exclusion of a translocation-negative CCS. Therefore, histological assessment is essential for the correct diagnosis of CCS. Primary CCS of the bone is exceedingly rare. Only a few cases of primary CCS arising in the ulna, metatarsals, ribs, radius, sacrum, and humerus have been reported, and primary CCS arising in the pubic bone has not been reported till date.

Case presentation

We present the case of an 81-year-old man with primary CCS of the pubic bone. Histological examination of the pubic bone revealed monomorphic small-sized cells arranged predominantly as a diffuse sheet with round, hyperchromatic nuclei and inconspicuous nucleoli. The cells had scant cytoplasm, and the biopsy findings indicated small round cell tumor (SRCT). Immunohistochemical staining revealed the tumor cells to be positive for HMB45, S100, and Melan-A but negative for cytokeratin (AE1/AE3) and epithelial membrane antigen. To the best of our knowledge, this is the first case report of primary CCS of the pubic bone resembling SRCT. This ambiguous appearance underscores the difficulties encountered during the histological diagnosis of this rare variant of CCS.

Conclusion

Awareness of primary CCS of the bone is clinically important for accurate diagnosis and management when the tumor is located in unusual locations such as the pubic bone and when the translocation t(12; 22)(q13; q12) is absent.
Appendix
Available only for authorised users
Literature
1.
go back to reference Enzinger FM: Clear-cell sarcoma of tendons and aponeuroses. An analysis of 21 cases. Cancer. 1965, 18: 1163-1174. 10.1002/1097-0142(196509)18:9<1163::AID-CNCR2820180916>3.0.CO;2-0.CrossRefPubMed Enzinger FM: Clear-cell sarcoma of tendons and aponeuroses. An analysis of 21 cases. Cancer. 1965, 18: 1163-1174. 10.1002/1097-0142(196509)18:9<1163::AID-CNCR2820180916>3.0.CO;2-0.CrossRefPubMed
2.
go back to reference Hocar O, Le Cesne A, Berissi S, Terrier P, Bonvalot S, Vanel D, Auperin A, Le Pechoux C, Bui B, Coindre JM, Robert C: Clear cell sarcoma (malignant melanoma) of soft parts: a clinicopathologic study of 52 cases. Dermatol Res Pract. in press. Hocar O, Le Cesne A, Berissi S, Terrier P, Bonvalot S, Vanel D, Auperin A, Le Pechoux C, Bui B, Coindre JM, Robert C: Clear cell sarcoma (malignant melanoma) of soft parts: a clinicopathologic study of 52 cases. Dermatol Res Pract. in press.
3.
go back to reference Panagopoulos I, Mertens F, Isaksson M, Mandahl N: Absence of mutations of the BRAF gene in malignant melanoma of soft parts (clear cell sarcoma of tendons and aponeuroses). Cancer Genet Cytogenet. 2005, 156: 74-76. 10.1016/j.cancergencyto.2004.04.008.CrossRefPubMed Panagopoulos I, Mertens F, Isaksson M, Mandahl N: Absence of mutations of the BRAF gene in malignant melanoma of soft parts (clear cell sarcoma of tendons and aponeuroses). Cancer Genet Cytogenet. 2005, 156: 74-76. 10.1016/j.cancergencyto.2004.04.008.CrossRefPubMed
4.
go back to reference Yang L, Chen Y, Cui T, Knösel T, Zhang Q, Geier C, Katenkamp D, Petersen I: Identification of biomarkers to distinguish clear cell sarcoma from malignant melanoma. Hum Pathol. in press. Yang L, Chen Y, Cui T, Knösel T, Zhang Q, Geier C, Katenkamp D, Petersen I: Identification of biomarkers to distinguish clear cell sarcoma from malignant melanoma. Hum Pathol. in press.
5.
go back to reference Sandberg AA, Bridge JA: Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: clear cell sarcoma (malignant melanoma of soft parts). Cancer Genet Cytogenet. 2001, 130: 1-7. 10.1016/S0165-4608(01)00462-9.CrossRefPubMed Sandberg AA, Bridge JA: Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: clear cell sarcoma (malignant melanoma of soft parts). Cancer Genet Cytogenet. 2001, 130: 1-7. 10.1016/S0165-4608(01)00462-9.CrossRefPubMed
6.
go back to reference Langezaal SM, van Roggen JF G, Cleton-Jansen AM, Baelde JJ, Hogendoorn PC: Malignant melanoma is genetically distinct from clear cell sarcoma of tendons and aponeurosis (malignant melanoma of soft parts). Br J Cancer. 2001, 84: 535-538. 10.1054/bjoc.2000.1628.CrossRefPubMedPubMedCentral Langezaal SM, van Roggen JF G, Cleton-Jansen AM, Baelde JJ, Hogendoorn PC: Malignant melanoma is genetically distinct from clear cell sarcoma of tendons and aponeurosis (malignant melanoma of soft parts). Br J Cancer. 2001, 84: 535-538. 10.1054/bjoc.2000.1628.CrossRefPubMedPubMedCentral
8.
go back to reference Zhang W, Shen Y, Wan R, Zhu Y: Primary clear cell sarcoma of the sacrum: a case report. Skeletal Radiol. 2011, 40: 633-639. 10.1007/s00256-010-1077-z.CrossRefPubMed Zhang W, Shen Y, Wan R, Zhu Y: Primary clear cell sarcoma of the sacrum: a case report. Skeletal Radiol. 2011, 40: 633-639. 10.1007/s00256-010-1077-z.CrossRefPubMed
9.
go back to reference Hersekli MA, Ozkoc G, Bircan S, Akpinar S, Ozalay M, Tuncer I, Tandogan RN: Primary clear cell sarcoma of rib. Skeletal Radiol. 2005, 34: 167-170. 10.1007/s00256-004-0801-y.CrossRefPubMed Hersekli MA, Ozkoc G, Bircan S, Akpinar S, Ozalay M, Tuncer I, Tandogan RN: Primary clear cell sarcoma of rib. Skeletal Radiol. 2005, 34: 167-170. 10.1007/s00256-004-0801-y.CrossRefPubMed
10.
go back to reference Fujimoto M, Hiraga M, Kiyosawa T, Murakami T, Murata S, Ohtsuki M, Nakagawa H: Complete remission of metastatic clear cell sarcoma with DAV chemotherapy. Clin Exp Dermatol. 2003, 28: 22-24. 10.1046/j.1365-2230.2003.01109.x.CrossRefPubMed Fujimoto M, Hiraga M, Kiyosawa T, Murakami T, Murata S, Ohtsuki M, Nakagawa H: Complete remission of metastatic clear cell sarcoma with DAV chemotherapy. Clin Exp Dermatol. 2003, 28: 22-24. 10.1046/j.1365-2230.2003.01109.x.CrossRefPubMed
11.
go back to reference Kato T, Suetake T, Sugiyama Y, Tabata N, Tagami H: Epidemiology and prognosis of subungual melanoma in 34 Japanese patients. Br J Dermatol. 1996, 134: 383-387. 10.1111/j.1365-2133.1996.tb16218.x.CrossRefPubMed Kato T, Suetake T, Sugiyama Y, Tabata N, Tagami H: Epidemiology and prognosis of subungual melanoma in 34 Japanese patients. Br J Dermatol. 1996, 134: 383-387. 10.1111/j.1365-2133.1996.tb16218.x.CrossRefPubMed
12.
go back to reference Sciot R, Speleman F: Clear cell sarcoma of soft tissue. World Health Organization classification of tumors. Pathology and genetics of tumors of soft tissue and bone. Edited by: Fletcher CDM, Unni KK, Mertens F. 2002, Lyon: IARC Press, 211-212. Sciot R, Speleman F: Clear cell sarcoma of soft tissue. World Health Organization classification of tumors. Pathology and genetics of tumors of soft tissue and bone. Edited by: Fletcher CDM, Unni KK, Mertens F. 2002, Lyon: IARC Press, 211-212.
13.
go back to reference Devoe K, Weidner N: Immunohistochemistry of small round-cell tumors. Semin Diagn Pathol. 2000, 17: 216-224.PubMed Devoe K, Weidner N: Immunohistochemistry of small round-cell tumors. Semin Diagn Pathol. 2000, 17: 216-224.PubMed
14.
go back to reference Bahrami A, Truong LD, Ro JY: Undifferentiated tumor: true identity by immunohistochemistry. Arch Pathol Lab Med. 2008, 132: 326-348.PubMed Bahrami A, Truong LD, Ro JY: Undifferentiated tumor: true identity by immunohistochemistry. Arch Pathol Lab Med. 2008, 132: 326-348.PubMed
15.
go back to reference Hendrickson MR, Ross JC: Neoplasms arising in congenital giant nevi: morphologic study of seven cases and a review of the literature. Am J Surg Pathol. 1981, 5: 109-135. 10.1097/00000478-198103000-00004.CrossRefPubMed Hendrickson MR, Ross JC: Neoplasms arising in congenital giant nevi: morphologic study of seven cases and a review of the literature. Am J Surg Pathol. 1981, 5: 109-135. 10.1097/00000478-198103000-00004.CrossRefPubMed
16.
go back to reference Barnhill RL, Flotte TJ, Fleischli M, Perez-Atayde A: Cutaneous melanoma and atypical Spitz tumors in childhood. Cancer. 1995, 76: 1833-1845. 10.1002/1097-0142(19951115)76:10<1833::AID-CNCR2820761024>3.0.CO;2-L.CrossRefPubMed Barnhill RL, Flotte TJ, Fleischli M, Perez-Atayde A: Cutaneous melanoma and atypical Spitz tumors in childhood. Cancer. 1995, 76: 1833-1845. 10.1002/1097-0142(19951115)76:10<1833::AID-CNCR2820761024>3.0.CO;2-L.CrossRefPubMed
17.
go back to reference Franquemont DW, Mills SE: Sinonasal malignant melanoma. A clinicopathologic and immunohistochemical study of 14 cases. Am J Clin Pathol. 1991, 96: 689-697.CrossRefPubMed Franquemont DW, Mills SE: Sinonasal malignant melanoma. A clinicopathologic and immunohistochemical study of 14 cases. Am J Clin Pathol. 1991, 96: 689-697.CrossRefPubMed
Metadata
Title
A rare case of primary clear cell sarcoma of the pubic bone resembling small round cell tumor: an unusual morphological variant
Authors
Shoko Nakayama
Taiji Yokote
Kazuki Iwaki
Toshikazu Akioka
Takuji Miyoshi
Yuji Hirata
Ayami Takayama
Uta Nishiwaki
Yuki Masuda
Motomu Tsuji
Toshiaki Hanafusa
Publication date
01-12-2012
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2012
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/1471-2407-12-538

Other articles of this Issue 1/2012

BMC Cancer 1/2012 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine